The Dopamine D


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 30 4 2019
medline: 19 11 2019
entrez: 30 4 2019
Statut: ppublish

Résumé

Activation of the renal D

Identifiants

pubmed: 31030607
doi: 10.1161/HYPERTENSIONAHA.119.12705
pmc: PMC6506374
mid: NIHMS1525782
doi:

Substances chimiques

Receptor, Angiotensin, Type 2 0
Receptors, Dopamine D1 0
Sodium 9NEZ333N27
Protein Phosphatase 2 EC 3.1.3.16

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1258-1265

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL074940
Pays : United States
Organisme : NIDDK NIH HHS
ID : P50 DK052612
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK039308
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128189
Pays : United States

Références

Clin Exp Hypertens. 2004 Apr;26(3):243-54
pubmed: 15132302
Hypertension. 2004 Feb;43(2):286-91
pubmed: 14718358
Semin Nephrol. 2005 Sep;25(5):322-7
pubmed: 16139687
Dan Med Bull. 1998 Jun;45(3):282-97
pubmed: 9675540
J Biol Chem. 1999 Apr 16;274(16):10999-1006
pubmed: 10196181
Am J Hypertens. 2017 Apr 1;30(4):339-347
pubmed: 27664954
Pflugers Arch. 2003 Feb;445(5):534-9
pubmed: 12634922
Hypertension. 2009 Feb;53(2):338-43
pubmed: 19075092
Am J Physiol Renal Physiol. 2016 Jan 15;310(2):F128-34
pubmed: 26290374
PLoS One. 2018 Apr 11;13(4):e0189464
pubmed: 29642240
Am J Physiol. 1993 Apr;264(4 Pt 2):R726-32
pubmed: 8476116
Kidney Int. 2014 Jul;86(1):118-26
pubmed: 24552847
Am J Physiol. 1990 Dec;259(6 Pt 2):F924-8
pubmed: 1979719
Kidney Blood Press Res. 1997;20(5):297-301
pubmed: 9419044
Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):543-50
pubmed: 12444495
Clin Exp Hypertens. 2000 Aug;22(6):635-44
pubmed: 10972167
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5573-8
pubmed: 9576924
Transl Res. 2015 Apr;165(4):505-11
pubmed: 25134060
Am J Physiol Renal Physiol. 2010 May;298(5):F1205-13
pubmed: 20181665
Kidney Int. 2006 Sep;70(6):1072-9
pubmed: 16850019
Eur J Pharmacol. 1994 Oct 14;269(2):265-8
pubmed: 7851503
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7271-5
pubmed: 10377404
Nat Clin Pract Nephrol. 2006 Nov;2(11):637-50
pubmed: 17066056
Hypertension. 2012 Aug;60(2):396-403
pubmed: 22710646
Hypertension. 2001 Sep;38(3):309-16
pubmed: 11566896
Hypertension. 2010 Sep;56(3):505-11
pubmed: 20660820
Clin Exp Pharmacol Physiol. 2013 Aug;40(8):527-34
pubmed: 23336117
Curr Hypertens Rep. 2007 Apr;9(2):148-53
pubmed: 17442227
Methods Mol Biol. 2013;945:329-45
pubmed: 23097116
Hypertension. 2012 Feb;59(2):437-45
pubmed: 22203736
Hypertension. 2012 Aug;60(2):387-95
pubmed: 22689743
Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3270-3276
pubmed: 28770955
Am J Hypertens. 1990 Jun;3(6 Pt 2):96S-99S
pubmed: 1974447
J Clin Invest. 1999 Jan;103(2):167-74
pubmed: 9916128
Hypertension. 2007 Jan;49(1):155-61
pubmed: 17116755
Hypertension. 2000 Dec;36(6):1053-8
pubmed: 11116124
Cell Signal. 2014 Nov;26(11):2521-9
pubmed: 25049074
Curr Opin Nephrol Hypertens. 2009 Jan;18(1):28-32
pubmed: 19077686
FEBS Lett. 2000 Sep 22;481(3):217-20
pubmed: 11007967
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2979-84
pubmed: 17301223
Hypertension. 2009 Nov;54(5):1070-6
pubmed: 19752292
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17985-90
pubmed: 17090678

Auteurs

John J Gildea (JJ)

From the Departments of Pathology (J.J.G., P.X., R.A.F.).

Peng Xu (P)

From the Departments of Pathology (J.J.G., P.X., R.A.F.).

Brandon A Kemp (BA)

Medicine (B.A.K., R.M.C.), University of Virginia, Charlottesville, VA.

Robert M Carey (RM)

Medicine (B.A.K., R.M.C.), University of Virginia, Charlottesville, VA.

Pedro A Jose (PA)

Division of Renal Disease & Hypertension Departments of Medicine and Pharmacology/Physiology, The George Washington University School of Medicine and Health Sciences, Washington DC (P.A.J.).

Robin A Felder (RA)

From the Departments of Pathology (J.J.G., P.X., R.A.F.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH